Enhanced anticancer efficiency of doxorubicin against human glioma by natural borneol through triggering ROS-mediated signal

Doxorubicin (DOX) as a first-line chemotherapeutic drug has been widely used for therapy of human cancers. However, side effects and chemo-resistance severely blocked its clinic application. Herein, natural borneol (NB) as a novel monoterpenoid chemosensitizer was found to have the potential to incr...

Full description

Bibliographic Details
Main Authors: Wen-qiang Cao, Ying Li, Ya-jun Hou, Mao-xun Yang, Xue-qi Fu, Bai-song Zhao, Han-ming Jiang, Xiao-yan Fu
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
ROS
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332219319304